proved that the overexpression of LOX activated the angiogenesis partially through increasing the VEGF and enhancing the tube formation ability of endothelial cells in tumor initiating cells (TICs)-enriched HCC, and LOX inhibitor β-aminopropionitrile (BAPN) reverses the angiogenesis (40). The gene discussed is VEGFA; the disease is hepatocellular carcinoma.